Literature DB >> 1656083

Relation of VP7 amino acid sequence to monoclonal antibody neutralization of rotavirus and rotavirus monotype.

B S Coulson1, C Kirkwood.   

Abstract

The neutralization epitopes of the VP7 of human rotavirus RV-4 were studied by using five neutralizing mouse monoclonal antibodies to select virus variants resistant to neutralization by each of the antibodies. Antibody resistance patterns and sequence analysis of the RV-4 variants revealed that at least four sites on VP7, located at amino acids 94 (region A), 147 to 148 (region B), 213 (region C), and 291, are involved in neutralization of the human G1 rotavirus RV-4. The A-region site elicited antibody cross-reactive between G types and showed species-restricted immunodominance not related to carbohydrate attachment. The monotype 1b rotavirus M37 lacked this site. The B region contained strain-specific and cross-reactive sites, absent in monotype 1c rotaviruses. The C-region site was present in all G1 rotaviruses tested. Monotype 1a rotaviruses contained all these sites of neutralization. Virus monotype and sensitivity to monoclonal antibody neutralization usually related to the presence of a particular amino acid(s) at or next to the positions at which the mutations were selected in the virus variants.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1656083      PMCID: PMC250261     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  41 in total

1.  Experience with an enzyme immunoassay for serotyping human group A rotaviruses.

Authors:  L E Unicomb; B S Coulson; R F Bishop
Journal:  J Clin Microbiol       Date:  1989-03       Impact factor: 5.948

Review 2.  Rotavirus gene structure and function.

Authors:  M K Estes; J Cohen
Journal:  Microbiol Rev       Date:  1989-12

3.  Nucleotide sequence of the gene encoding the serotype-specific antigen of human (Wa) rotavirus: comparison with the homologous genes from simian SA11 and UK bovine rotaviruses.

Authors:  M A Richardson; A Iwamoto; N Ikegami; A Nomoto; Y Furuichi
Journal:  J Virol       Date:  1984-09       Impact factor: 5.103

4.  Definition of human rotavirus serotypes by plaque reduction assay.

Authors:  R G Wyatt; H B Greenberg; W D James; A L Pittman; A R Kalica; J Flores; R M Chanock; A Z Kapikian
Journal:  Infect Immun       Date:  1982-07       Impact factor: 3.441

5.  Sequence homology between human and animal rotavirus serotype-specific glycoproteins.

Authors:  M L Dyall-Smith; I H Holmes
Journal:  Nucleic Acids Res       Date:  1984-05-11       Impact factor: 16.971

6.  Antigenic relationships among human rotaviruses as determined by outer capsid protein VP4.

Authors:  M Gorziglia; G Larralde; A Z Kapikian; R M Chanock
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

7.  Neutralization epitopes on rotavirus SA11 4fM outer capsid proteins.

Authors:  M Gorziglia; G Larralde; R L Ward
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

8.  Sequence analysis of the gene encoding the serotype-specific glycoprotein (VP7) of two new human rotavirus serotypes.

Authors:  K Y Green; Y Hoshino; N Ikegami
Journal:  Virology       Date:  1989-02       Impact factor: 3.616

9.  A porcine rotavirus strain with dual VP7 serotype specificity.

Authors:  H S Nagesha; J Huang; C P Hum; I H Holmes
Journal:  Virology       Date:  1990-03       Impact factor: 3.616

10.  Comparison of rotavirus immunoglobulin A coproconversion with other indices of rotavirus infection in a longitudinal study in childhood.

Authors:  B S Coulson; K Grimwood; P J Masendycz; J S Lund; N Mermelstein; R F Bishop; G L Barnes
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

View more
  37 in total

1.  Amino acid substitution within the VP7 protein of G2 rotavirus strains associated with failure to serotype.

Authors:  M I Gómara; D Cubitt; U Desselberger; J Gray
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

2.  Comparisons of rotavirus VP7-typing monoclonal antibodies by competition binding assay.

Authors:  P Raj; D O Matson; B S Coulson; R F Bishop; K Taniguchi; S Urasawa; H B Greenberg; M K Estes
Journal:  J Clin Microbiol       Date:  1992-03       Impact factor: 5.948

3.  Heterogeneity and temporal dynamics of evolution of G1 human rotaviruses in a settled population.

Authors:  Serenella Arista; Giovanni M Giammanco; Simona De Grazia; Stefania Ramirez; Concetta Lo Biundo; Claudia Colomba; Antonio Cascio; Vito Martella
Journal:  J Virol       Date:  2006-08-23       Impact factor: 5.103

4.  Detection and genetic characterization of group A rotavirus strains circulating among children with acute gastroenteritis in Japan.

Authors:  Tung Gia Phan; Pattara Khamrin; Trinh Duy Quang; Shuvra Kanti Dey; Sayaka Takanashi; Shoko Okitsu; Niwat Maneekarn; Hiroshi Ushijima
Journal:  J Virol       Date:  2007-02-14       Impact factor: 5.103

5.  Mutated G4P[8] rotavirus associated with a nationwide outbreak of gastroenteritis in Nicaragua in 2005.

Authors:  Filemon Bucardo; Beatrice Karlsson; Johan Nordgren; Margarita Paniagua; Alcides González; Juan Jose Amador; Felix Espinoza; Lennart Svensson
Journal:  J Clin Microbiol       Date:  2007-01-17       Impact factor: 5.948

6.  Typing of human rotavirus VP4 by an enzyme immunoassay using monoclonal antibodies.

Authors:  B S Coulson
Journal:  J Clin Microbiol       Date:  1993-01       Impact factor: 5.948

7.  Single point mutations may affect the serotype reactivity of serotype G11 porcine rotavirus strains: a widening spectrum?

Authors:  M Ciarlet; Y Hoshino; F Liprandi
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

8.  Epidemiology of symptomatic human rotaviruses in Bangalore and Mysore, India, from 1988 to 1994 as determined by electropherotype, subgroup and serotype analysis.

Authors:  S Aijaz; K Gowda; H V Jagannath; R R Reddy; P P Maiya; R L Ward; H B Greenberg; M Raju; A Babu; C D Rao
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

9.  Human rotavirus VP4 contains strain-specific, serotype-specific and cross-reactive neutralization sites.

Authors:  C D Kirkwood; R F Bishop; B S Coulson
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

10.  Cross-reactive, serotype- and monotype-specific neutralization epitopes on VP7 of serotype G3 and G5 porcine rotavirus strains.

Authors:  M Ciarlet; M Hidalgo; F Liprandi
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.